(Q47586850)

English

Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital

scientific article published on 25 June 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

Neurological opportunistic infections and neurological immune reconstitution syndrome: impact of one decade of highly active antiretroviral treatment in a tertiary hospital (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

opportunistic infection

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

3

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

4

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

6

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

9

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

author name string

M Riveiro-Barciela

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

E Van den Eynde

5

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

S Villar del Saz

7

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

I Ocaña

8

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

M Crespo

10

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

A Pahissa

11

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

publication date

25 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

14

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

1

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

21-30

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Recovery of the immune system with antiretroviral therapy: the end of opportunism?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Immune reconstitution disease of the central nervous system.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Immune reconstitution inflammatory syndrome: more answers, more questions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Central nervous system infections in individuals with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Neurological complications of immune reconstitution in HIV-infected populations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Causes of the first AIDS-defining illness and subsequent survival before and after the advent of combined antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Cryptococcal immune reconstitution inflammatory syndrome after antiretroviral therapy in AIDS patients with cryptococcal meningitis: a prospective multicenter study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Clinical indicators of immune restoration following highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Timing of initiation of antiretroviral drugs during tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Clinical Course and Prognostic Factors of Progressive Multifocal Leukoencephalopathy in Patients Treated with Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01033.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2012.01033.X

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 February 2018

http://europepmc.org/abstract/MED/22726389

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47586850&oldid=2160813060"